Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non–Small-Cell Lung Cancer in the First-Line Setting? In their recent article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback